Biodesix Announces Phase 3 Clinical Trial Collaboration with Kadmon

News   Mar 02, 2012

 
Biodesix Announces Phase 3 Clinical Trial Collaboration with Kadmon
 
 
 

RELATED ARTICLES

Funding Approved to Further Metabolomics Research

News

The NIH Common Fund Metabolomics Program has been approved for a second stage of support from fiscal years 2018-2021.

READ MORE

Finding Drug Targets for Obesity, Diabetes

News

Technological breakthrough will likely be of great interest to biotechnology companies aspiring to build their drug pipeline in the metabolic disease area.

READ MORE

Arsenic Exposure in U.S. Public Drinking Water Declines Following New EPA Regulations

News

New research found that exposure to arsenic in drinking water was significantly reduced among Americans using public water systems following the Environmental Protection Agency regulation on maximum levels of arsenic. However, there were no improvements in arsenic exposure rates among users of private wells, which are not federally regulated.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE